- Home
- POM vs PAXS Comparison
POM vs PAXS Comparison
Compare POM & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POM
- PAXS
- Stock Information
- Founded
- POM 2015
- PAXS 2021
- Country
- POM China
- PAXS United States
- Employees
- POM N/A
- PAXS N/A
- Industry
- POM Other Specialty Stores
- PAXS Investment Managers
- Sector
- POM Consumer Discretionary
- PAXS Finance
- Exchange
- POM Nasdaq
- PAXS Nasdaq
- Market Cap
- POM 640.8M
- PAXS 710.4M
- IPO Year
- POM 2025
- PAXS N/A
- Fundamental
- Price
- POM $4.31
- PAXS $16.02
- Analyst Decision
- POM
- PAXS
- Analyst Count
- POM 0
- PAXS 0
- Target Price
- POM N/A
- PAXS N/A
- AVG Volume (30 Days)
- POM 1.3M
- PAXS 195.0K
- Earning Date
- POM 01-01-0001
- PAXS 01-01-0001
- Dividend Yield
- POM N/A
- PAXS 11.72%
- EPS Growth
- POM N/A
- PAXS N/A
- EPS
- POM N/A
- PAXS N/A
- Revenue
- POM $46,931,528.00
- PAXS N/A
- Revenue This Year
- POM N/A
- PAXS N/A
- Revenue Next Year
- POM N/A
- PAXS N/A
- P/E Ratio
- POM N/A
- PAXS N/A
- Revenue Growth
- POM 12.37
- PAXS N/A
- 52 Week Low
- POM $3.35
- PAXS $12.57
- 52 Week High
- POM $6.43
- PAXS $15.93
- Technical
- Relative Strength Index (RSI)
- POM N/A
- PAXS 58.08
- Support Level
- POM N/A
- PAXS $15.36
- Resistance Level
- POM N/A
- PAXS $15.71
- Average True Range (ATR)
- POM 0.00
- PAXS 0.22
- MACD
- POM 0.00
- PAXS 0.04
- Stochastic Oscillator
- POM 0.00
- PAXS 91.67
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.